Literature DB >> 7214740

Immune response to rabbit liver-specific lipoprotein in acute viral hepatitis.

L Ortona, V Laghi, R Cauda, P Nervo.   

Abstract

A serial prospective study of cell-mediated immunity to rabbit liver-specific lipoprotein (RLSP) has been done in 26 patients with acute viral hepatitis (AH) (18 HBsAg+ and eight HBsAg-) using a lymphocyte transformation test. An increased stimulation index was recorded in 56% of HBsAg+ cases and in 63% of the HBsAg- group at the first determination within 2 weeks of presentation. A progressive return to normal values was observed during the course of the disease. In one patient, however, the stimulation index remained high at 6 months after presentation and liver biopsy showed the appearance of chronic active hepatitis. Results within the normal range of values were observed when a macromolecular kidney protein fraction was used as antigen: further evidence of an organ-specific component in RLSP preparation to which the immune response seems to be directed. These findings demonstrate the existence of a common and time-limited sensitization to RLSP in acute viral hepatitis irrespective of HBsAg status. It is suggested that RLSP may be a useful alternative to human LSP in evaluating immune reactions in liver diseases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7214740      PMCID: PMC1537165     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis.

Authors:  W M Lee; W D Reed; C G Mitchell; R M Galbraith; A L Eddleston; A J Zuckerman; R Williams
Journal:  Br Med J       Date:  1975-03-29

2.  Lymphocyte transformation test with liver-specific protein and phytohaemagglutinin in patients with liver disease.

Authors:  K Thestrup-Pedersen; K Ladefoged; P Andersen
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

3.  Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis.

Authors:  A D Thomson; M A Cochrane; I G McFarlane; A L Eddleston; R Williams
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

4.  [Cellular immune reactions towards homologous liver-specific antigens (HLP) in chronic inflammatory liver diseases (author's transl)].

Authors:  K H von Meyer zum Büschenfelde; J Knolle; J Berger
Journal:  Klin Wochenschr       Date:  1974-03-01

5.  Cell-mediated immune responses in chronic liver diseases.

Authors:  M G Smith; P L Golding; A L Eddleston; C G Mitchell; A Kemp; R Williams
Journal:  Br Med J       Date:  1972-02-26

6.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

7.  Liver-specific antigens of different species. II. Localization of a membrane antigen at cell surface of isolated hepatocytes.

Authors:  U Hopf; K H Meyer zum Büschenfelde; J Freudenberg
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

8.  Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

Authors:  A M Cochrane; A Moussouros; A D Thomsom; A L Eddleston; R Wiiliams
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

9.  Organ-specificity and diagnostic value of cell-mediated immunity against a liver-specific membrane protein: studies in hepatic and non-hepatic diseases.

Authors:  K H Meyer zum Büschenfelde; A Alberti; W Arnold; J Freudenberg
Journal:  Klin Wochenschr       Date:  1975-11-15

10.  Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

Authors:  J Miller; M G Smith; C G Mitchell; W D Reed; A L Eddleston; R Williams
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

View more
  4 in total

1.  In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis.

Authors:  M Mondelli; A Alberti; F Tremolada; R Williams; A L Eddleston; G Realdi
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

2.  Characterization and demonstration of human liver-specific protein (LSP) and apo-LSP.

Authors:  N Lebwohl; M A Gerber
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

3.  Study of cellular immunity in experimental autoimmune hepatitis in mice.

Authors:  Y Mori; T Mori; H Yoshida; S Ueda; K Iesato; Y Wakashin; M Wakashin; K Okuda
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

4.  Incidence of antibodies against rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.

Authors:  L Ortona; V Laghi; E Tamburrini; L Troncone; N Bonifazi; P Nervo; R Cauda
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.